{"prompt": "['MC1752', '50', '10.551 Pregnancy', 'Pregnancy should be reported in an expedited manner as Grade 3 \"Pregnancy,', 'puerperium and perinatal conditions - Other (pregnancy)\" under', 'the', 'Pregnancy, puerperium and perinatal conditions SOC. Pregnancy should be', 'followed until the outcome is known.', '10.552 Fetal Death', 'Fetal death is defined in CTCAE as \"A disorder characterized by death in utero;', 'failure of the product of conception to show evidence of respiration, heartbeat, or', 'definite movement of a voluntary muscle after expulsion from the uterus, without', 'possibility of resuscitation.\"', 'Any fetal death should be reported expeditiously, as Grade 4 \"Pregnancy,', 'puerperium and perinatal conditions - Other (pregnancy loss)\" under the', 'Pregnancy, puerperium and perinatal conditions SOC.', '10.553 Death Neonatal', 'Neonatal death, defined in CTCAE as \"A disorder characterized by cessation of', 'life occurring during the first 28 days of life\" that is felt by the investigator to be', 'at least possibly due to the investigational agent/intervention, should be reported', 'expeditiously.', 'A neonatal death should be reported expeditiously as Grade 4 \"General', 'disorders and administration - Other (neonatal loss)\" under the General', 'disorders and administration SOC.', '10.6', 'Required Routine Reporting', '10.61', 'Baseline and Adverse Events Evaluations', 'Pretreatment symptoms/conditions to be graded at baseline and adverse events to be', 'graded at each evaluation.', 'Grading is per CTCAE v5.0 unless alternate grading is indicated in the table below:', 'Each', 'System Organ Class (SOC)', 'Adverse event/Symptoms', 'Baseline', 'evaluation', 'General disorders and', 'Pain', 'X', 'X', 'administration site', 'Fatigue', 'X', 'X', 'conditions', 'Injury, poisoning and', 'Dermatitis Radiation', 'X', 'X', 'procedural complications', 'Metabolism and nutrition', 'Anorexia', 'X', 'X', 'disorders', 'Musculoskeletal and', 'Bone pain', 'X', 'X', 'connective tissue disorders', 'Vascular disorders', 'Lymphedema', 'X', 'X', 'Respiratory, thoracic and', 'Pneumonitis', 'X', 'X', 'mediastinal disorders', 'Pulmonary fibrosis', 'X', 'X', 'Renal and urinary disorders', 'Hematuria', 'X', 'X', 'Protocol Version Date: 21JUN2018']['MC1752', '51', 'Each', 'System Organ Class (SOC)', 'Adverse event/Symptoms', 'Baseline', 'evaluation', 'Urinary frequency', 'X', 'X', 'Urinary incontinence', 'X', 'X', 'Urinary retention', 'X', 'X', 'Urinary tract obstruction', 'X', 'X', 'Urinary tract pain', 'X', 'X', 'Urinary urgency', 'X', 'X', 'Number of stools', 'X', 'Diarrhea', 'X', 'Constipation', 'X', 'Fecal incontinence', 'X', 'X', 'Gastrointestinal disorders', 'Nausea', 'X', 'X', 'Proctitis', 'X', 'X', 'Rectal hemorrhage', 'X', 'X', 'Vomiting', 'X', 'X', '10.62', 'All other AEs', 'Submit via appropriate MCCC Case Report Forms (i.e., paper or electronic, as', 'applicable) the following AEs experienced by a patient and not specified in', 'Section 10.6:', '10.621 Grade 2 AEs deemed possibly, probably, or definitely related to the study', 'treatment or procedure.', '10.622 Grade 3 and 4 AEs regardless of attribution to the study treatment or', 'procedure.', '10.623 Grade 5 AEs (Deaths)', \"10.6231Any death within 30 days of the patient's last study treatment or\", 'procedure regardless of attribution to the study treatment or', 'procedure.', \"10.6232Any death more than 30 days after the patient's last study\", 'treatment or procedure that is felt to be at least possibly', 'treatment related must also be submitted as a Grade 5 AE, with a', 'CTCAE type and attribution assigned.', '10.7', 'Late Occurring Adverse Events', 'Refer to the instructions in the Forms Packet (or electronic data entry screens, as applicable)', 'regarding the submission of late occurring AEs following completion of the Active Monitoring', 'Phase (i.e., compliance with Test Schedule in Section 4.0).', '10.8', 'EMD Serono - Additional Event Reporting Instructions', 'The following reportable events must be submitted to EMD Serono within 24 hours (or', 'immediately for death or life-threatening events) using the applicable safety report form provided.', 'Serious Adverse Events', 'Exposure during Pregnancy or Breastfeeding (even if not associated with an adverse', 'event)', 'Protocol Version Date: 21JUN2018']\n\n###\n\n", "completion": "END"}